Vascular Reparative Mechanism in Diabetes



Status:Active, not recruiting
Conditions:Ocular, Diabetes
Therapuetic Areas:Endocrinology, Ophthalmology
Healthy:No
Age Range:18 - Any
Updated:9/20/2018
Start Date:October 30, 2011
End Date:June 30, 2020

Use our guide to learn which trials are right for you!

Vascular Reparative Mechanism by ACE2/Ang-(1-7) in Diabetes

The purpose of this research study is to study blood stem cells in diabetic patients and
normal patients. We would like to better understand if these cells, called endothelial
precursor cells (EPCs), are not working as expected in people with diabetes. We would like to
see if the function of these cells can predict the development of diabetic retinopathy.

Diabetic retinopathy is an eye disease associated with diabetes in which the cells of the
retina are damaged. It can cause blurred vision, vision loss, blindness or possible bleeding
in the retina. Even with current treatments, the quality of life for people with diabetic
retinopathy is much reduced.


Inclusion Criteria:

- Men or women 18 years or older

- 39 type 1 or type 2 diabetic patients

- 13 with mild retinopathy

- 13 with moderate retinopathy

- 13 with severe, nonproliferative retinopathy

- 39 age and sex matched healthy controls

Exclusion Criteria:

- Current pregnancy as evidence by a urine pregnancy test as the blood from a pregnant
female will influence the results of the laboratory tests
We found this trial at
1
site
Birmingham, Alabama 35294
?
mi
from
Birmingham, AL
Click here to add this to my saved trials